Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines

Chemistry and Biodiversity

Volumn 2, Issue 9, 2005, Pages 1217-1231

  Ding, Hongxia ^a   Lu, Wei ^b   Li, Haibo ^a   Yang, Leixiang ^a   Zhang, Qijun ^a   Zhou, Changxin ^a   Wu, Xiumei ^c   Baudoin, Olivier ^d   Cai, Junchao ^b   Guéritte, Françoise ^d   Zhao, Yu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c Zhejiang Hisun Naturelite Pharmaceutical R and D Co Ltd   (China)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (2 CHLOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (2 FLUOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (2,6 DIFLUOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (3 CHLOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (3 FLUOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (3 METHYLBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (4 CHLOROBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 2 (4 METHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 3,4 DIHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 2 BENZOYL 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 1,2,3,4 TETRAHYDRO 6,7 (METHYLENEDIOXY)ISOQUINOLINE; 3,4,5 TRIS(BENZYLOXY) N [2 [3,4 (METHYLENEDIOXY)PHENYL]ETHYL]BENZAMIDE; 3,4,5 TRIS(BENZYLOXY) N [2 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL]ETHYL]BENZAMIDE; 4 (BENZYLOXY) 3,5 DIMETHOXY N [2 (4 METHOXYPHENYL)ETHYL]BENZAMIDE; 4 (BENZYLOXY) 3,5 DIMETHOXY N [2 [3,4 (METHYLENEDIOXY)PHENYL]ETHYL]BENZAMIDE; 4 (BENZYLOXY) N [2 (3 BENZYLOXYPHENYL)ETHYL] 3,5 DIMETHOXYBENZAMIDE; 4 (BENZYLOXY) N [2 [4 (BENZYLOXY)PHENYL]ETHYL] 3,5 DIMETHOXYBENZAMIDE; 4 (BENZYLOXY) N [2 [4 (BENZYLOXYPHENYL) 3,5 DIMETHOXYPHENYL]ETHYL] 3,5 DIMETHOXYBENZAMIDE; 6 (BENZYLOXY) 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 3,4 DIHYDROISOQUINOLINE; 6,7 (METHYLENEDIOXY) 1 [3,4,5 TRIS(BENZYLOXY)PHENYL]ISOQUINOLINE; 7 (BENZYLOXY) 1 [3,4,5 TRIS(BENZYLOXY)PHENYL] 6,8 DIMETHOXYISOQUINOLINE; 7 (BENZYLOXY) 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 1,2,3,4 TETRAHYDRO 6,8 DIMETHOXYISOQUINOLINE; 7 (BENZYLOXY) 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 3,4 DIHYDRO 6,8 DIMETHOXYISOQUINOLINE; 7 (BENZYLOXY) 1 [4 (BENZYLOXY) 3,5 DIMETHOXYPHENYL] 6,8 DIMETHOXYISOQUINOLINE; ANTINEOPLASTIC ALKALOID; ISOQUINOLINE DERIVATIVE; LIGNAN DERIVATIVE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CYTOTOXICITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOLECULAR MODEL; QUANTITATIVE STRUCTURE PROPERTY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; ISOQUINOLINES; LIGNANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 26044436557     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200590092     Document Type: Article

References (18)

1. R. S. Ward, Nat. Prod. Rep. 1999, 16, 75.
2. C. Canel, R. M. Moraes, F. E. Dayan, D. Ferreira, Phytochemistry 2000, 54, 115;
3. T. Imbert, Biochimie 1998, 80, 207.
4. H. Stähelin, A. von Wartburg, Cancer Res. 1991, 51, 5;
5. K. R. Hande, Eur. J. Cancer 1998, 34, 1514.
6. Z. Y. Xiao, K. F. Bastow, J. R. Vance, R. S. Sidwell, H. K. Wang, M. S. Chen, Q. Shi, K. H. Lee, J. Med. Chem. 2004, 47, 5140;
7. P. Meresse, C. Monneret, E. Bertounesque, Tetrahedron 2004, 60, 2657;
8. J. Z. López-Pérez, E. del Olmo, B. de Pascual-Teresa, A. Abad, A. San Feliciano, Bioorg. Med. Chem. Lett. 2004, 14, 1283.
9. C. Tratrat, S. Giorgi-Renault, H. P. Husson, Org. Lett. 2002, 4, 3187;
10. Y. Hitotsuyanagi, M. Fukuyo, K. Tsuda, M. Kobayashi, A. Ozeki, H. Itokawa, K. Takeya, Bioorg. Med. Chem. Lett. 2000, 10, 315;
11. E. Marcantoni, M. Petrini, R. Profeta, Tetrahedron Lett. 2004, 45, 2133.
12. F. Leteurtre, J. Madalengoitia, A. Orr, T. J. Cuzi, E. K. Lehnert, T. Macdonald, Y. Pommier, Cancer Res. 1992, 52, 4478.
13. J. S. Madalengoitia, J. J. Tepe, K. A. Werbovetz, E. K. Lehnert, T. L. Macdonald, Bioorg. Med. Chem. 1997, 5, 1807.
14. H. N. ElSohly, G. E. Ma, C. E. Turner, M. A. ElSohly, J. Nat. Prod. 1984, 47, 445.
15. J. McNulty, J. A. Steere, S. Wolf, Tetrahedron Lett. 1998, 39, 8013.
16. A. S. Capilla, M. Romero, M. D. Pujol, D. H. Caignard, P. Renard, Tetrahedron 2001, 57, 8297.
17. R. D. Cramer, D. E. Patterson, J. D. Bunce, J. Am. Chem. Soc. 1988, 110, 5959.
18. T. Araki, Y. Enokido, N. Inamura, S. Aizawa, H, Hatanaka, Brain Res. 1998, 794, 239.